Clinical utility of a two-site immunoradiometric assay for creatine kinase-MB in the detection of perioperative myocardial infarction
- St. Luke's Episcopal Hospital, Houston, TX
In 144 patients, creatine kinase MB was measured serially at 0, 8, 16, 24, 48 and 72 h using a two-site immunoradionmetric assay (IRMA). Cardiac enzymes were also measured, including SGOT, LDH, total CPK, and CK-MB by electrophoresis. The presence of perioperative myocardial infarction (poMI) was established in 24 patients by the appearance of new electrocardiographic Q waves and/or new wall motion abnormalities detected by radionuclide ventriculography. In patients without poMI, CK-MB (IRMA) was elevated at 0 to 8 h but decreased by 16 h. In patients with poMI, peak values occurred at 16 to 24 h. Using a threshold value of 8.5 EU/I, patients with poMI could be distinguished from those without with 97% accuracy (sensitivity = 88%, specificity = 99%). We conclude that the CK-MB (IRMA) can serve as a valuable postoperative screening tet for poMI.
- OSTI ID:
- 5744806
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 24:8
- Country of Publication:
- United States
- Language:
- English
Similar Records
Scintigraphic, electrocardiographic, and enzymatic diagnosis of perioperative myocardial infarction in patients undergoing myocardial revascularization
Validation of technetium-99m stannous pyrophosphate myocardial scintigraphy for diagnosing acute myocardial infarction more than 48 hours old when serum creatine kinase-MB has returned to normal
Related Subjects
MYOCARDIAL INFARCTION
DIAGNOSIS
PHOSPHOTRANSFERASES
RADIOIMMUNOASSAY
ELECTROCARDIOGRAMS
ELECTROPHORESIS
PATIENTS
CARDIOVASCULAR DISEASES
DIAGRAMS
DISEASES
ENZYMES
ISOTOPE APPLICATIONS
PHOSPHORUS-GROUP TRANSFERASES
RADIOASSAY
TRACER TECHNIQUES
TRANSFERASES
550601* - Medicine- Unsealed Radionuclides in Diagnostics